Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swoop (formerly SRAXmd) is a healthcare-focused data and technology company that provides pharmaceutical brands with advanced tools for patient and healthcare provider (HCP) audience discovery. By leveraging machine learning and a vast repository of privacy-safe real-world data, the company creates precise audience segments based on clinical behavior and patient journeys. Its platform enables life science companies to optimize digital marketing strategies, ensuring that relevant medical information reaches the right stakeholders at the right time. Originally the medical division of SRAX, the company was acquired by Halyard Capital in 2019 and subsequently merged with Swoop before being acquired by Real Chemistry in 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SRAXmd.